Send any enquiries to TRIALS - Acute stroke trials invite patients to participate within a short time period after the onset of stroke symptoms - up to 12 hours, 72 hours, 96 hours and 120 hours.ĬHARM: A phase 3 study to evaluate the efficacy and safety of intravenous BIIB093 (Glibenclamide) for severe cerebral edema following large hemispheric infarction For full information, click on the link at the end of each section. Ongoing clinical trials are listed below, some of which are open for recruitment. Ongoing clinical trials contribute to our understanding of the causes of stroke, treatment and recovery.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |